End of the year data reveals a thrilling climb in the total value locked in decentralized finance (defi), which ballooned by 133.8% over the past year. December capped off this …
ZURICH (Reuters) -Switzerland’s Roche will acquire U.S. biopharma firm Poseida Therapeutics in a cash deal worth up to $1.5 billion, the companies said on Tuesday. Poseida is to be bought …
